137 related articles for article (PubMed ID: 21245)
21. beta 1-Adrenoceptors mediating relaxation of the guinea-pig trachea: experiments with prenalterol, a beta 1-selective adrenoceptor agonist.
Johansson U; Waldeck B
J Pharm Pharmacol; 1981 Jun; 33(6):353-6. PubMed ID: 6115005
[TBL] [Abstract][Full Text] [Related]
22. Blockade of central beta-adrenergic receptors by tazolol (1-isopropylamino-3-(2-thiazoloxy)-2-propanol).
Skolnick P; Stalvey LP; Daly JW
Life Sci; 1977 Dec; 21(11):1655-63. PubMed ID: 23478
[No Abstract] [Full Text] [Related]
23. Demonstration of the beta 2-adrenoceptor intrinsic efficacy of AY-28,925 using the PGF2 alpha-contracted guinea-pig trachea.
Heaslip RJ; Giesa FR; Rimele TJ; Grimes D
Eur J Pharmacol; 1987 Jun; 137(2-3):179-84. PubMed ID: 2886349
[TBL] [Abstract][Full Text] [Related]
24. An homogeneous population of beta 1-adrenoceptors subserves inhibitory responses in guinea-pig ileal preparations.
Mian MA; Malta E; Raper C
J Pharm Pharmacol; 1984 Oct; 36(10):698-9. PubMed ID: 6150092
[TBL] [Abstract][Full Text] [Related]
25. Hexoprenaline: beta-adrenoreceptor selectivity in isolated tissues from the guinea-pig.
O'Donnell SR; Wanstall JC
Clin Exp Pharmacol Physiol; 1975; 2(6):541-7. PubMed ID: 207477
[TBL] [Abstract][Full Text] [Related]
26. Beta 2-adrenoceptor selectivity in four series of beta-adrenoceptor agonists.
Johansson LH; Persson H; Rosengren E
Eur J Pharmacol; 1986 Oct; 130(1-2):97-103. PubMed ID: 2877893
[TBL] [Abstract][Full Text] [Related]
27. Theoretical and practical problems with the assessment of intrinsic efficacy of agonists: efficacy of reputed beta-1 selective adrenoceptor agonists for beta-2 adrenoceptors.
Kenakin TP
J Pharmacol Exp Ther; 1982 Nov; 223(2):416-23. PubMed ID: 6127403
[TBL] [Abstract][Full Text] [Related]
28. Species difference in the beta1/beta2-adrenoceptor selectivity of SM220CL in the cat and guinea-pig.
Bohmer K; Raper C
Clin Exp Pharmacol Physiol; 1977; 4(4):349-58. PubMed ID: 198170
[TBL] [Abstract][Full Text] [Related]
29. Comparison of interactions of R(+)- and S(-)-isomers of beta-adrenergic partial agonists, befunolol and carteolol, with high affinity site of beta-adrenoceptors in the microsomal fractions from guinea-pig ciliary body, right atria and trachea.
Koike K; Horinouchi T; Takayanagi I
Gen Pharmacol; 1994 Nov; 25(7):1477-81. PubMed ID: 7896063
[TBL] [Abstract][Full Text] [Related]
30. Basic pharmacological properties of prenalterol.
Mattsson H; Hedberg A; Carlsson E
Acta Med Scand Suppl; 1982; 659():9-37. PubMed ID: 6127902
[No Abstract] [Full Text] [Related]
31. Functional identification of rat atypical beta-adrenoceptors by the first beta 3-selective antagonists, aryloxypropanolaminotetralins.
Manara L; Badone D; Baroni M; Boccardi G; Cecchi R; Croci T; Giudice A; Guzzi U; Landi M; Le Fur G
Br J Pharmacol; 1996 Feb; 117(3):435-442. PubMed ID: 8821531
[TBL] [Abstract][Full Text] [Related]
32. In vitro assessment of the selectivities of various beta-adrenergic blocking agents.
Dreyer AC; Offermeier J
Life Sci; 1980 Dec; 27(22):2087-92. PubMed ID: 6111008
[No Abstract] [Full Text] [Related]
33. The cardiovascular pharmacology and hemodynamic activity of tazolol, a selective myocardial beta-stimulant.
Strosberg AM
Arch Int Pharmacodyn Ther; 1976 Aug; 222(2):200-15. PubMed ID: 10864
[TBL] [Abstract][Full Text] [Related]
34. Partial agonist activity of celiprolol, a cardioselective beta-antagonist.
Ochi S; Nakazawa M; Kimura T; Nakagawa Y; Imai S
Eur J Pharmacol; 1991 Feb; 194(1):1-5. PubMed ID: 1676370
[TBL] [Abstract][Full Text] [Related]
35. A comparison of the activities of the beta-adrenoceptor agonists MJ9184-1 AND (--)-ISOPRENALINE IN GUINEA-PIG AND CAT PREPARATIONS.
Davey T; Malta E; Raper C
Clin Exp Pharmacol Physiol; 1974; 1(1):43-52. PubMed ID: 4156198
[No Abstract] [Full Text] [Related]
36. Beta-adrenoceptor selectivity of dobutamine: in vivo and in vitro studies.
Maccarrone C; Malta E; Raper C
J Cardiovasc Pharmacol; 1984; 6(1):132-41. PubMed ID: 6199596
[TBL] [Abstract][Full Text] [Related]
37. Beta-adrenoceptor studies. 1. In vitro beta-adrenergic blocking, antiarrhythmic, and local anesthetic activities of a new series of aromatic bis(2-hydroxy-3-isopropylaminopropyl) ethers.
Zaagsma J; Nauta WT
J Med Chem; 1974 May; 17(5):507-13. PubMed ID: 4151492
[No Abstract] [Full Text] [Related]
38. A study of the conformational requirements for direct adrenergic stimulation.
Gray AP; Reit E; Ackerly JA; Hava M
J Med Chem; 1973 Sep; 16(9):1023-7. PubMed ID: 4147657
[No Abstract] [Full Text] [Related]
39. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
[TBL] [Abstract][Full Text] [Related]
40. Evidence from agonist and antagonist studies to suggest that the beta1-adrenoceptors subserving the positive inotropic and chronotropic responses of the heart do not belong to two separate subgroups.
Lumley P; Broadley KJ
J Pharm Pharmacol; 1977 Oct; 29(10):598-604. PubMed ID: 21238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]